Vemurafenib mucosal side-effect.

Pileri, A; Cricca, M; Gandolfi, L; Misciali, C; Casadei, B; Zinzani, P L; Patrizi, A

Pileri, A; Cricca, M; Gandolfi, L; Misciali, C; Casadei, B; Zinzani, P L; Patrizi, A.

Afiliação

Pileri A; Dermatology Unit, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
Cricca M; Division Dermatology, Departement of Surgery and Translational Medicine, University of Florence, Florence, Italy.
Gandolfi L; Microbiology Unit, Department Of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
Misciali C; Haematogy Unit, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
Casadei B; Dermatology Unit, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
Zinzani PL; Haematogy Unit, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
Patrizi A; Haematogy Unit, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

J Eur Acad Dermatol Venereol ; 30(6): 1053-5, 2016 Jun.

Article em En | MEDLINE | ID: mdl-25764320

Assuntos

Antineoplásicos/efeitos adversos; Indóis/efeitos adversos; Sulfonamidas/efeitos adversos; Feminino; Humanos; Pessoa de Meia-Idade; Vemurafenib

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Indóis / Antineoplásicos Limite: Female / Humans / Middle aged Idioma: En Revista: J Eur Acad Dermatol Venereol Assunto da revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google